News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

American BioScience, Inc. And American Pharmaceutical Partners (APPX) To Present Six Abstracts On Applications Of Nanoparticle Albumin Bound (nab(TM)) Tumor Targeting Technology At The 97th American Association for Cancer Research Annual Meeting



4/5/2006 2:17:13 PM

American Pharmaceutical Partners, Inc. (NASDAQ:APPX - News) and American Bioscience Inc. (ABI) today announced the presentation of data at the 97th Annual Meeting of the American Association of Cancer Research (AACR) that further highlights its proprietary nanoparticle albumin-bound (nab(TM)) tumor-targeting technology.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES